Toshiba has selected Canon as the winning bidder for subsidiary Toshiba Medical Systems.
Toshiba’s board on Wednesday afternoon granted Canon preferential negotiating rights. Canon’s bid is worth more than 700 billion yen ($6.21 billion). Board members believe the limited overlap between the two companies’ operations will lead to smooth antitrust proceedings.
Selling the medical unit would help Toshiba rebuild its finances and invest in growth segments. The electronics maker is still reeling from a major accounting scandal.
Canon, Fujifilm Holdings and a coalition of Konica Minolta and U.K. investment fund Permira took part in the second round of bidding for Toshiba Medical on Friday. Now, Toshiba and Canon will seek to iron out the details.
Canon sees medical equipment as a new priority field. It wants another revenue source to complement the camera and office equipment markets — its mainstays. The company already offers medical products, such as retinal cameras, but it wants to expand into diagnostic imaging equipment, such as CT scanners and MRI machines.
The global medical equipment market is projected to be worth more than 50 trillion yen in 2018, up from nearly 40 trillion yen in 2013.
Full content: The Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas